| Name | Title | Contact Details |
|---|
At Dart NeuroScience we are visionaries` innovators` and optimists. We are not a typical pharmaceutical company. We are a discovery catalyst` perfectly positioned and structured to make a serious difference in our world. Curious and creative` hopeful and driven – all joined together to fulfill our vision: protect and enhance the quality of mind. With open minds and open hearts` we stretch our limits every day so that we can continue to improve life and the way we live it.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.
Emergent Health Corp. is a public company (trading under the symbol EMGE) dedicated to the betterment of its shareholders and product consumers. We believe we have a developing product line to become a leader in the field of Regenerative Medicine and improved neutraceuticals and phytonutritionals to be available to the general public without a prescription.
Central Health Medicare Plan is a Covina, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Lane Regional Medical Center, we value community and take pride in the role we play as caregivers. It is an honor to say that we serve as the primary healthcare resource for more than 200,000 of our neighbors located throughout Zachary and the surrounding region of Baker, Central, Clinton, Jackson, St. Francisville, New Roads, North Baton Rouge and Southern Mississippi. As part of our continued dedication to serving our community and providing the highest quality of care, we continue to recruit new physicians to the area and to provide access to the very best healthcare services, technologies and programs available in the region.